(Press-News.org) Scientists have long known that the body rids itself of excess copper and various other minerals by collecting them in the liver and excreting them through the liver's bile. However, a new study led by Johns Hopkins researchers and published June 22 in PLoS ONE suggests that when this route is impaired there's another exit route just for copper: A molecule sequesters only that mineral and routes it from the body through urine.
The researchers, led by Svetlana Lutsenko, Ph.D., a professor of physiology at the Johns Hopkins University School of Medicine, found this additional copper escape hatch by studying an animal model of Wilson's disease, a rare disorder most often diagnosed in children. People with this disease accumulate abnormally large amounts of copper in the liver, eventually leading to liver damage and failure.
Micronutrients such as copper, zinc and iron are indispensible for human development. Copper is required for embryonic development, respiration, and cardiovascular function, among other processes; too little copper can be fatal whereas too much can cause neurological impairment and organ failure.
One diagnostic test for Wilson's disease is to check for high amounts of copper in the urine; copper levels could be especially high in advanced stages of this disorder. For decades doctors and scientists have blamed this high urinary copper on the breakdown of cells in the liver, which purportedly dumped their contents into the bloodstream as they died. These contents were thought to be picked up by the kidneys and eventually excreted in the urine.
However, Lutsenko says, this theory had never been tested. To verify this explanation, she and her colleagues examined mice genetically modified to have Wilson's disease. As in people, these animals' liver function gradually worsens over time due to copper accumulation. Eventually the animals' livers regenerate and liver function improves and with this the researchers expected to see less urinary copper. However, at this stage in the disease, urinary copper in the animal models continued to increase. Additionally, the researchers found no increased urine concentrations of other minerals stored in liver cells, which would be expected if these cells were releasing all their entire contents and not just copper. Together, these findings suggest that liver cell death isn't the main source of urinary copper in Wilson's disease.
Delving deeper, the researchers gave the mice radioactive copper, which they could trace as it made its way through the body. They found that when copper reached a certain threshold level in the liver, it was directed it to the kidneys instead. At the same time, they saw that levels of a protein used to transport copper to the liver decreased. Both of these observations strengthened the idea that another mechanism must exist to remove copper from the body.
To figure out what that mechanism might be, Lawrence Gray, a graduate student on Lutsenko's team searched the animals' urine to see what molecules copper might be bound to. Their pursuit turned up an unidentified molecule that they've temporarily named "small copper carrier," or SCC. Further tests showed that as liver function decreased, more SCC appeared in the animals' blood, and that SCC could compete for copper with the proteins that normally transport this mineral to the liver.
"These findings all suggest that SCC indeed represents a previously unknown agent that the body uses to excrete excess copper," Lutsenko explains.
She and her colleagues are now trying to learn more about SCC, both to identify this molecule and to determine whether it could be a unique marker that's only present during Wilson's disease. If so, it could save pediatric patients the pain of liver biopsy, a test often used to definitively diagnose this condition. In addition, SCC may also represent a treatment for this rare disorder. If scientists could develop a way to raise SCC concentration in the blood, Lutsenko says, it could increase copper export and prevent further harm to the liver.
###
This study was funded by the National Institutes of Health grants 5F31DK084730, 5R01DK079209, and 5P01GM067166. The mass-spectrometry work was done at the Oregon Health and Science University, supported by NIH instrumentation grant S10-RR025512.
Authors on the paper are Lawrence Gray, Venkata S. Pendyala, Abigael Muchenditsi and Svetlana Lutsenko of Johns Hopkins; Fangyu Peng of University of Texas Southwestern Medical Center; Shannon A. Molloy and Jack H. Kaplan of University of Illinois at Chicago; Otto Muzik of Wayne State University, School of Medicine, Detroit, Michigan; and Jaekwon Lee of University of Nebraska, Lincoln.
For more information, go to:
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038327
http://physiology.bs.jhmi.edu/pages/faculty/detail.aspx?PID=345
http://www.hopkinsmedicine.org/institute_basic_biomedical_sciences/about_us/scientists/svetlana_lutsenko.html
END
1. Trans Fat Restrictions Result in Healthier Fast Food Meals for NYC Residents
Reduction in Trans Fat Consumption Can Reduce Cardiovascular Disease Risk
(Sound bites and b-roll footage available. See bottom of page for feed dates, times, and coordinates)
Trans fat, such as partially hydrogenated oil, is a mostly processed form of fat that significantly increases risk for coronary heart disease. Just 40 calories of trans fat a day can increase risk for heart disease by up to 23 percent. In 2006 New York City issued unprecedented restrictions on the use of trans fats ...
July 16, 2012 – (BRONX, NY) – Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that people with a form of mild cognitive impairment (MCI), a risk factor for developing Alzheimer's disease, have twice the risk of dying compared with cognitively normal people. Those with dementia have three times the risk. The findings are being presented at the Alzheimer's Association International Conference in Vancouver this week.
Amnestic MCI is a condition in which people have memory problems more severe than normal for ...
A new study from the European Centre for Environment & Human Health, Peninsula College of Medicine and Dentistry, University of Exeter, has revealed that people living near the coast tend to have better health than those living inland.
Researchers from the Centre used data from the UK's census to examine how health varied across the country, finding that people were more likely to have good health the closer they live to the sea. The analysis also showed that the link between living near the coast and good health was strongest in the most economically deprived communities.
The ...
VIDEO:
This video shows relative movement paths of 224 radio-tagged palm seeds handled by rodents on Barro Colorado Island, Panama. Colored dots mark locations of 129 seeds that were found eaten...
Click here for more information.
Big seeds produced by many tropical trees were probably once ingested and then defecated whole by huge mammals called gomphotheres that dispersed the seeds over large distances. But gomphotheres were probably hunted to extinction more than 10,000 ...
ONCOLOGY
A new target in acute myeloid leukemia | Back to top
Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development. Dr. Daniel Tenen and colleagues from Harvard University in Boston discovered a new pathway activated by FLT3 mutation. Their results show ...
Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development. Dr. Daniel Tenen and colleagues from Harvard University in Boston discovered a new pathway activated by FLT3 mutation. Their results show that cyclin dependent kinase 1 (CDK1), a critical regulator of cell ...
Ticagrelor, a blood-thinning drug approved by the FDA in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or some heart attacks, according to joint updated guidelines issued by the American Heart Association (AHA) Task Force on Practice Guidelines and the American College of Cardiology (ACCF) Foundation.
The "focused update" on unstable angina (chest pain) or a specific kind of heart attack known as non-ST-elevation myocardial infarction (NSTEMI) is published in Circulation: Journal ...
CORVALLIS, Ore. – A new study suggests that higher blood pressure is associated with lower mortality in extremely frail, elderly adults.
The study, published today in the Journal of the American Medical Association's (JAMA) Archives of Internal Medicine, looked at a nationally representative group of 2,340 adults ages 65 and older. The researchers found that lower blood pressure protected healthier, robust older adults but the same may not be true for their more frail counterparts.
Lead author Michelle Odden, a public health epidemiologist at Oregon State University, ...
CHICAGO – A study suggests that safety-net hospitals (SNHs), which typically care for poor patients, performed more poorly than other hospitals on nearly every measure of patient experience and that could have financial consequences as hospital payments are connected to performance, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
Value-based purchasing (VBP), a program run by the Centers for Medicare and Medicaid Services (CMS), now ties part of each hospital's payments to its performance on a set of quality measures. ...
COLUMBIA, Mo. – Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, University of Missouri scientists have found a more efficient way of targeting prostate tumors by using gold nanoparticles and a compound found in tea leaves. This new treatment would require doses that are thousands of times smaller than chemotherapy and do not travel through the body inflicting ...
